Biotechnology Daily
Page 3 of 25-
Aug 31 · 11:23Biotechnology Daily
AstraZeneca's Oral Relaxin Drug Clears Phase 2b Bar at ESC26
-
Aug 31 · 09:27Biotechnology Daily
Repatha Cuts Death Risk 20% in 12,000-Patient Amgen Trial
-
Aug 30 · 20:25Biotechnology Daily
Roche Widens FDA Clearance for Test Behind Jazz's Ziihera
-
Aug 30 · 16:05Biotechnology Daily
Tessier-Lavigne Releases Emails to Rebut Book's Fraud Claims
-
Aug 30 · 14:57Biotechnology Daily
FDA Clears Roivant's Dermatomyositis Drug, but ROIV Slides 7.6%
-
Aug 30 · 13:44Biotechnology Daily
Arrowhead's Redemplo Data Puts Ionis on Notice in Munich
-
Aug 30 · 12:35Biotechnology Daily
Wainua Trial Miss Puts AstraZeneca's Amyloidosis Bet in Doubt
-
Aug 30 · 11:25Biotechnology Daily
Cytokinetics Puts a Second Approval in Reach as CYTK Slides 7.5%
-
Aug 30 · 09:59Biotechnology Daily
AstraZeneca's Heart Trial Miss Casts Doubt on Silencer Drugs
-
Aug 30 · 09:25Biotechnology Daily
Cytokinetics Takes Myqorzo Data to Munich as CYTK Falls 7.5%
-
Aug 30 · 08:47Biotechnology Daily
AstraZeneca's Relaxin Pill Splits Its Mid-Stage Heart Data
-
Aug 29 · 14:58Biotechnology Daily
FDA Clears Gilead's Bixlenvo as a Biktarvy Switch Option
-
Aug 29 · 12:39Biotechnology Daily
CRISPR Therapeutics Bets on Top Dose After Mixed Year-One Data
-
Aug 29 · 11:22Biotechnology Daily
Novartis's Pacibekitug Cuts Inflammation, but Hearts Come Next
-
Aug 29 · 08:46Biotechnology Daily
Novartis Takes Its IL-6 Antibody Into Phase 3 After Novo's Miss
-
Aug 28 · 13:40Biotechnology Daily
Mounjaro's $9.94 Billion Franchise Gains a Heart-Risk Label
-
Aug 28 · 12:33Biotechnology Daily
BioNTech and Genentech Drop Phase 2 mRNA Cancer Vaccine Trial
-
Aug 28 · 11:22Biotechnology Daily
Mounjaro Wins FDA Nod to Cut Cardiovascular Risk
-
Aug 27 · 20:21Biotechnology Daily
Gilead Wins Another FDA Nod, Widening Lenacapavir's Reach
-
Aug 27 · 17:53Biotechnology Daily
RevMed Prices Its RAS Pancreatic Cancer Pill Above $475,000
-
Aug 27 · 13:43Biotechnology Daily
CEPI Puts Up to $16.5 Million Behind Minapharm's Bundibugyo Shot
-
Aug 26 · 20:24Biotechnology Daily
Pancreatic Cancer Approval Lands, RVMD Swings 10% Intraday
-
Aug 26 · 12:31Biotechnology Daily
FDA Clears Revolution Medicines' Daraxonrasib in Pancreatic Cancer
-
Aug 26 · 08:48Biotechnology Daily
Spyre Shelves Rheumatoid Arthritis Bet After TL1A Miss